However, blocking TIM-4 effectively prevents this sequestration and proliferation-induced suppression, leading to enhance effectiveness of anti-PD-1 therapy and adoptive T cell therapy in mouse models by enabling improved tumor targeting and activation of CD8+ T cells [252]. This evidence concerns the gene CD8A and neoplasm.